Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Nephrostomies in obstructive uropathy; how should hormone resistant prostate cancer patients be managed and can we predict who will benefit?

Prostate Cancer and Prostatic Diseases volume 9, pages 42–44 (2006)Cite this article

Abstract

Current opinion advocates the use of nephrostomies in hormone naive patients with obstructive uropathy while hormone resistant patients require an individual approach. Patients undergoing a nephrostomy for uropathy were retrospectively analysed, with particular interest in hormone status and blood levels. Over a 46-month period, 26/112 nephrostomies were performed for prostate cancer induced uropathy. Survival was 226.5 days for hormone naive patients, 114.3 days in the responsive group and 100.2 days if resistant. Bilateral cases survived 72.1 days versus 157.6 days for unilateral patients. All patients should be considered for nephrostomy despite their hormone status.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Paul AB, Love C, Chisholm GD . The management of bilateral ureteric obstruction and renal failure in advanced prostate cancer. Br J Urol 1994; 74: 642–645.

    Article  CAS  Google Scholar 

  2. Markowitz DM, Wong KT, Laffey KJ, Bixon R, Nagler HM, Martin EC . Maintaining quality of life after palliative diversion for malignant ureteral obstruction. Urol Radiol 1989; 11: 129–132.

    Article  CAS  Google Scholar 

  3. Colombel M, Mallame W, Abbou CC . Influence of urological complications on the prognosis of prostate cancer. Eur Urol 1997; 31: 21–24.

    Article  Google Scholar 

  4. BAUS. Guidelines for the Management of Metastatic Prostate Cancer 2005.

  5. Dowling RA, Carrasco CH, Babaian RJ . Percutaneous urinary diversion in patients with hormone-refractory prostate cancer. Urology 1991; 37: 89–91.

    Article  CAS  Google Scholar 

  6. Hamdy FC, Williams JL . Use of dexamethasone for ureteric obstruction on advanced prostate cancer: percutaneous nephrostomies can be avoided. Br J Urol 1995; 75: 782–785.

    Article  CAS  Google Scholar 

  7. Lau MW, Temperley DE, Mehta S, Johnson RJ, Barnard RJ, Clarke NW . Urinary tract obstruction and nephrostomy drainage in pelvic malignant disease. Urol 1995; 76: 565–569.

    CAS  Google Scholar 

  8. Van Dyke AH, Van Nagell JR . The prognostic significance of ureteral obstruction in patients with recurrent carcinoma of the cervix uteri. Surg Gynaecol Obstetr 1975; 141: 371–373.

    CAS  Google Scholar 

  9. Chiou RK, Chang WY, Horan JJ . Ureteral obstruction associated with prostate cancer: the outcome after percutaneous nephrostomy. J Urol 1990; 143: 957–959.

    Article  CAS  Google Scholar 

  10. Fallon B, Olney L, Culp DA . Nephrostomy in cancer patients: to do or not to do? Br J Urol 1980; 52: 237–242.

    Article  CAS  Google Scholar 

  11. Sandhu DP, Mayor PE, Sambrook PA, George NJ . Outcome and prognostic factors in patients with advanced prostate cancer and obstructive uropathy. Br J Urol 1992; 70: 412–416.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank the radiology department for their expertise and assistance.

Author information

Authors and Affiliations

  1. Taunton and Somerset NHS Trust, Musgrove Park Hospital, Taunton, Somerset, UK

    M R E Harris & M J Speakman

Authors
  1. M R E Harris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M J Speakman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M R E Harris.

Additional information

The authors confirm that this is an original piece of work that has not been submitted for publication elsewhere. As a retrospective study, no ethical permission or patient consent was obtained. Patient confidentiality has been protected.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harris, M., Speakman, M. Nephrostomies in obstructive uropathy; how should hormone resistant prostate cancer patients be managed and can we predict who will benefit?. Prostate Cancer Prostatic Dis 9, 42–44 (2006). https://doi.org/10.1038/sj.pcan.4500858

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500858

Keywords

This article is cited by

Search

Advanced search

Quick links